These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6765359

  • 1. [Influence of culture conditions (oxygenation) on the residual virulence of Brazil-BCG and Glaxo-BCG vaccines in mice].
    Feitosa JG, Gontijo Filho PP.
    An Microbiol (Rio J); 1982; 27():51-67. PubMed ID: 6765359
    [No Abstract] [Full Text] [Related]

  • 2. [Influence of the inoculation route on residual virulence of different substrains of BCG for albino mice].
    Palhano Junior L, Gontijo Filho PP.
    Rev Inst Med Trop Sao Paulo; 1980; 22(1):15-9. PubMed ID: 7001603
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Residual virulence of lyophilized commercial BCG-Brazil vaccine, and of the one cultured in Dubos media for mice].
    Fonseca Lde S, Gontijo Filho PP.
    An Microbiol (Rio J); 1979; 24():182-9. PubMed ID: 400665
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of Bacillus Calmette-Guérin on immunosuppression from cyclophosphamide, methotrexate, and 5-fluorouracil.
    Sparks FC, Albert NE, Andreone PA, Breeding JH.
    Cancer Res; 1977 Aug; 37(8 Pt 1):2560-4. PubMed ID: 326388
    [No Abstract] [Full Text] [Related]

  • 8. Indirect migration inhibition test in xenogeneic systems. I. Delayed hypersensitivity to BCG.
    Skopińska E, Zaleska-Rutczyńska Z, Wasik M, Komender A, Ostrowski K.
    Bull Acad Pol Sci Biol; 1969 Aug; 17(10):589-93. PubMed ID: 4909017
    [No Abstract] [Full Text] [Related]

  • 9. Pathogenesis of pulmonary Mycobacterium bovis infection: basic principles established by the rabbit model.
    Dannenberg AM.
    Tuberculosis (Edinb); 2001 Aug; 81(1-2):87-96. PubMed ID: 11463228
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Variability of the BCG Moreau substrain. I. Comparison of morphology and residual virulence of BCG substrains of various origins].
    Janaszek W.
    Med Dosw Mikrobiol; 1983 Aug; 35(2):85-95. PubMed ID: 6369042
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test"].
    Buraczewska M, Chodkowska S, Paklerska-Pobratyn H.
    Gruzlica; 1969 Feb; 37(2):93-9. PubMed ID: 4891544
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cellular regulation of lung granuloma formation and delayed- type hypersensitivity induced with BCG cell walls. Further evidence of involvement of cellular immunity in lung granuloma formation.
    Yamamoto K, Kato K, Kakinuma M, Brehmer W.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):357-68. PubMed ID: 7043952
    [Abstract] [Full Text] [Related]

  • 18. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety.
    Chen JM, Islam ST, Ren H, Liu J.
    Vaccine; 2007 Nov 23; 25(48):8114-22. PubMed ID: 17954004
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.